A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India
Conditions: Plaque Psoriasis; Psoriatic Arthritis Intervention: Drug: Ixekizumab Sponsor: Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arthritis | India Health | Psoriasis | Psoriatic Arthritis | Research | Rheumatology | Study